We've detected an Ad Blocker in your browser.

Please disable or pause the Ad Blocker and refresh the page to be able to register and access the website normally.

Menu

Obstructive Hypertrophic Cardiomyopathy: Getting it Right First Time

10 January 2023
19:45 GMT | 20:45 CET | 14:45 EST

REGISTER FREE

LOG IN

Already registered? Please log in using your email address.

Please enter your email address

Having trouble logging in? Please email info@radcliffe-group.com

validation result

Please choose one of the options shown

Please enter your registration lead id

Please enter your registration session id

Please enter your successful log-in count

on_demand_log_in

Please choose one of the options shown

Radcliffe Medical Education

Overview

This educational broadcast will leverage an expert faculty to distil the importance of making correct and timely diagnosis of HCM and how to do it.

In lieu of recent European guidance, this activity will leverage guidance from imaging experts in the field of HCM, to provide a practical approach to diagnosing HCM and considering best course of treatment.


REGISTER FREE



Learning Objectives

Following attendance at this broadcast, physicians will be able to:

  • Recall the general approach to diagnosis and stratification of HCM according to the latest guidelines and expert opinion
  • Apply advanced echocardiographic methodologies to equivocal HCM diagnoses
  • Select appropriate imaging modalities to facilitate accurate risk stratification
  • Stratify patients based on specific risk features and disease severity
  • Choose suitable treatment modalities for patients based on specific disease features and severity

This live event starts in:

DAYS
:

HOURS
:

MINS
:

SECS

This programme is supported through an educational grant from Bristol Myers Squibb.

This programme, ‘Obstructive Hypertrophic Cardiomyopathy: Getting it Right First Time’ is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 CME point, equating to 1 hour of learning.

EBACISCP

Programme

(Please note this programme is subject to change)

Unmet Needs in oHCM (5 mins)
  • Current rates of HCM
  • Sudden cardiac death
  • Mimics the phenocopies and the need for accurate diagnosis. When should we consider a diagnosis?
  • At risk individuals/why suspect HCM?
  • Overview of diagnostic approach
    • Initial investigations
      • Physical examinations, family history, ECG
    • Imaging

Role of Echocardiography in Hypertrophic Cardiomyopathy (20 mins)

In this session, the diagnostic relevance of echo will be explored through the use of case examples

  • Establishing a diagnosis (and excluding other causes)
  • Evaluating severity and SCD risk
    • Structural and functional abnormalities
    • LVOTO characterisation
    • Presence of LV apical aneurysm

CMR: When To Use It (10 mins)
  • Equivocal diagnoses
  • Additional prognostic features: LV apical aneurysm; mitral valve abnormalities
  • Assessment of myocardial fibrosis
  • Septal reduction pre-planning

Phenotyping and Treatment Selection (10 mins)
  • Selecting treatment based on disease severity
    • ICD considerations – when to use
    • Pharmacological management
      • Foundational treatment for symptom relief
      • Direct myosin inhibitors
        • The role of echo in initiation and maintenance
      • When to consider septal reduction?

REGISTER FREE

Faculty

Prof Marc Dweck

Professor of Clinical Cardiology, University of Edinburgh, UK

Professor Marc Dweck is the Professor of Clinical Cardiology and Consultant at the University of Edinburgh, UK. He is an EACVI Board Member with clinical interests in multi-modality imaging and cardiac device implantation His research program is centred around the use of multi-modality imaging (echo, CT, CMR, PET) to improve our understanding of cardiovascular pathophysiology and ultimately to improve patient assessment, care and outcomes. In particular he has focused on coronary atherosclerosis, aortic stenosis and cardiomyopathy. He has published in many of the leading medical and cardiovascular journals and is the recipient of numerous national and international awards (e.g. Michael Davies Award; Sir Jules Thorn Award; BHF Outstanding Investigator Award, Parmley Prize JACC). He is currently the Chief Investigator of two ongoing RCTs trials of novel therapeutic strategies in aortic stenosis (SALTIRE 2 NCT02132026 & EVOLVED NCT03094143).

More info

Close info

Dr Milind Desai

Director of Center for Hypertrophic Cardiomyopathy, Cleveland Clinic Foundation, US

Dr Desai works in the Cardiovascular Medicine and Heart and Vascular Institute at the Cleveland Clinic, US. He is the Director of Clinical Operations and Center for Hypertrophic Cardiomyopathy, the Medical Director of the Center for Aortic Diseases, the Medical Director for Center for Radiation Heart Disease and an integral part of the Center for Valvular heart disease.

More info

Close info

Dr Carolyn Ho

Medical Director of the Cardiovascular Genetics Center, Brigham and Women’s Hospital, US

Dr Carolyn Ho is the medical director of the Cardiovascular Genetics Center at Brigham and Women’s Hospital in Boston, US. Dr Ho is also an associate professor of medicine at Harvard Medical School. Dr Ho’s clinical interests include cardiomyopathy, echocardiography, and cardiovascular genetics.

More info

Close info

Prof Robin Nijveldt

Professor of Cardiovascular Imaging and Cardiologist, Radboud University Medical Centre, NL

Prof Robin Nijveldt is Professor of Cardiovascular Imaging and Cardiologist at the Radboud University Medical Center in Nijmegen, NL and connected to the Radboud Institute for Health Sciences. He works at the department of Cardiology and focusses on the Vascular damage research theme, with a special interest in Cardiovascular Magnetic Resonance imaging, CT and echocardiography, and in close collaboration with the department of Radiology. He explores new imaging techniques and innovative strategies on today’s scientific health challenges, and aims to improve patient outcome in a personalized approach.

More info

Close info

REGISTER FREE

About Radcliffe Cardiology

We are Radcliffe, a knowledge network for the cardiovascular community

We’re here to bring cardiovascular knowledge, insight and innovation to life for clinicians around the world, using our communications and creative expertise, our platforms and connections across the community to help transform theory into practice faster and more effectively.

We bring medical knowledge to life

From great science writing and smart journal editing, the curation of evidence based and peer-reviewed content, to engaging new formats that cut through the noise, we believe that communication is at the heart of great healthcare.

Our work is underpinned by 3 core principles:

  • We build on the best science
  • We work hands-on with our community
  • We bring fresh thinking

Our promise is that we’ll equip you with the latest knowledge and skills you need, to do the best for your patients.

For more information on Radcliffe Cardiology, please visit www.radcliffecardiology.com.